Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer’s disease patients

被引:0
|
作者
Claire Bridel
Torsten Hoffmann
Antje Meyer
Sisi Durieux
Marleen A. Koel-Simmelink
Matthias Orth
Philip Scheltens
Inge Lues
Charlotte E. Teunissen
机构
[1] VU University Medical Centre Amsterdam,Neurochemistry Lab and Biobank, Department of Clinical Chemistry
[2] Probiodrug AG,Department of Neurology, Alzheimer Center
[3] Swiss BioQuant AG,undefined
[4] VU University Medical Centre Amsterdam,undefined
来源
Alzheimer's Research & Therapy | / 9卷
关键词
Alzheimer’s disease; Cerebrospinal fluid; Glutaminyl cyclase; Amyloid beta; 3pE-Aβ42;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients
    Bridel, Claire
    Hoffmann, Torsten
    Meyer, Antje
    Durieux, Sisi
    Koel-Simmelink, Marleen A.
    Orth, Matthias
    Scheltens, Philip
    Lues, Inge
    Teunissen, Charlotte E.
    ALZHEIMERS RESEARCH & THERAPY, 2017, 9
  • [2] Glutaminyl cyclase activity is a characteristic feature of human cerebrospinal fluid
    Gontsarova, Anastassia
    Kaufmann, Eckhard
    Tumani, Hayrettin
    Dressel, Alexander
    Mandel, Friedrich
    Wiesmueller, Karl-Heinz
    Kunert-Kell, Christiane
    Brinkmeier, Heinrich
    CLINICA CHIMICA ACTA, 2008, 389 (1-2) : 152 - 159
  • [3] Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals
    Gunn, Adam P.
    Wong, Bruce X.
    McLean, Catriona
    Fowler, Chris
    Barnard, Peter J.
    Duce, James A.
    Roberts, Blaine R.
    JOURNAL OF NEUROCHEMISTRY, 2021, 156 (06) : 979 - 987
  • [4] Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease
    Molina, JA
    Jiménez-Jiménez, FJ
    Vargas, C
    Gómez, P
    de Bustos, F
    Gómez-Escalonilla, C
    Zurdo, M
    Tallón, A
    Martínez-Salio, A
    Porta-Etessam, J
    Villanueva, C
    Arenas, J
    ACTA NEUROLOGICA SCANDINAVICA, 2002, 106 (06): : 347 - 350
  • [5] Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease
    Navarro, JA
    Molina, JA
    JimenezJimenez, FJ
    BenitoLeon, J
    OrtiPareja, M
    Gasalla, T
    CabreraValdivia, F
    Vargas, C
    deBustos, F
    Arenas, J
    ACTA NEUROLOGICA SCANDINAVICA, 1996, 94 (06): : 411 - 414
  • [6] Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease
    J. A. Molina
    F. J. Jiménez-Jiménez
    A. Hernánz
    E. Fernández-Vivancos
    S. Medina
    F. de Bustos
    C. Gómez-Escalonilla
    Y. Sayed
    Journal of Neural Transmission, 2002, 109 : 1035 - 1044
  • [7] Cerebrospinal fluid levels of selenium in patients with Alzheimer's disease
    Meseguer, I
    Molina, JA
    Jiménez-Jiménez, FJ
    Aguilar, MV
    Mateos-Vega, CJ
    González-Muñoz, MJ
    de Bustos, F
    Ortí-Pareja, M
    Zurdo, M
    Berbel, A
    Barrios, E
    Martínez-Para, MC
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (3-4) : 309 - 315
  • [8] Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease
    Rubio, JC
    de Bustos, F
    Molina, JA
    Jiménez-Jiménez, FJ
    Benito-León, J
    Martín, MA
    Campos, Y
    Ortí-Pareja, M
    Cabrera-Valdivia, F
    Arenas, J
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 155 (02) : 192 - 195
  • [9] Cerebrospinal fluid levels of phosphotau in patients with Alzheimer's disease
    Sakka, P
    Nikolaou, C
    Lymperopoulou, O
    Efthymiou, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S299 - S299
  • [10] Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease
    Molina, JA
    Jiménez-Jiménez, FJ
    Hernánz, A
    Fernández-Vivancos, E
    Medina, S
    de Bustos, F
    Gómez-Escalonilla, C
    Sayed, Y
    JOURNAL OF NEURAL TRANSMISSION, 2002, 109 (7-8) : 1035 - 1044